Saxagliptin 5 mg combined with Metformin Hydrochloride (ER) 500 mg is an advanced oral antidiabetic formulation designed for the effective management of type 2 diabetes mellitus. This combination works synergistically to maintain healthy blood glucose levels, improve insulin sensitivity, and support better glycemic control in patients who may not achieve adequate results with lifestyle modifications alone. The extended-release (ER) form of Metformin ensures a gradual and consistent release of the active ingredient, providing long-lasting effects with reduced gastrointestinal discomfort compared to immediate-release formulations.
Saxagliptin belongs to the class of DPP-4 inhibitors, which enhance the bodys natural incretin hormones, stimulating insulin release and reducing glucagon secretion in response to meals. Metformin HCl (ER) is a biguanide that reduces hepatic glucose production and improves peripheral insulin sensitivity. Together, this combination addresses multiple pathways involved in type 2 diabetes, ensuring effective glycemic management.
Uses:
Treatment of type 2 diabetes mellitus in adults.
Used in combination with diet and exercise to improve blood sugar control.
Helps in patients who need dual-action therapy to manage fasting and postprandial glucose levels.
Key Benefits:
Dual Mechanism of Action: Combines DPP-4 inhibition with insulin sensitivity improvement for effective glycemic control.
Reduced Blood Sugar Levels: Helps maintain both fasting and post-meal glucose within healthy ranges.
Extended-Release Advantage: Metformin ER ensures a gradual release, reducing gastrointestinal side effects and providing convenience with fewer doses.
Weight Neutral: Saxagliptin is generally weight-neutral, reducing concerns of weight gain associated with some antidiabetic medications.
Cardiovascular Safety: When used as prescribed, it supports heart health without major adverse cardiovascular effects.
Side Effects:
While generally well-tolerated, Saxagliptin + Metformin ER may cause:
Common: Nausea, vomiting, diarrhea, abdominal discomfort, and mild headache.
Less Common: Upper respiratory infections, dizziness, joint pain.
Rare but Serious: Lactic acidosis (with Metformin, especially in kidney impairment), pancreatitis (with Saxagliptin), severe allergic reactions, or hypoglycemia when combined with other antidiabetic agents.
Precaution: Patients with kidney, liver, or heart conditions should consult their doctor before use. Regular monitoring of blood sugar levels is recommended.